Roelof Rongen
2016
In 2016, Roelof Rongen earned a total compensation of $560K as Chief Executive Officer at Matinas BioPharma Holdings, a 5% increase compared to previous year.
Compensation breakdown
| Bonus | $160,000 |
|---|---|
| Option Awards | $116,250 |
| Salary | $283,750 |
| Total | $560,000 |
Rongen received $283.8K in salary, accounting for 51% of the total pay in 2016.
Rongen also received $160K in bonus and $116.3K in option awards.
Rankings
In 2016, Roelof Rongen's compensation ranked 10,784th out of 14,075 executives tracked by ExecPay. In other words, Rongen earned more than 23.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,784 out of 14,075 | 23rd |
Division Manufacturing | 4,188 out of 5,488 | 24th |
Major group Chemicals And Allied Products | 1,490 out of 1,900 | 22nd |
Industry group Drugs | 1,198 out of 1,543 | 22nd |
Industry Pharmaceutical Preparations | 934 out of 1,173 | 20th |
Source: SEC filing on September 14, 2017.
Rongen's colleagues
We found two more compensation records of executives who worked with Roelof Rongen at Matinas BioPharma Holdings in 2016.